Susan Drapeau

Dr. Drapeau has over 25 years of industry experience in cell therapy, biologics, biomaterials, protein therapies and medical device development. Currently with Dark Horse Regenerative Medicine, Susan leads projects with numerous client partners across development, landscape assessment, regulatory strategy, manufacturing tech transfer, and business evaluation to accelerate their portfolio.  Prior to Dark Horse Consulting, Dr. Drapeau was a key contributor at  Sigilon Therapeutics, Vericel Corporation, Medtronic and Osiris Therapeutics.  Dr. Drapeau holds a PhD in chemical engineering from Rice University.